loading

Alnylam Pharmaceuticals Inc (ALNY) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
30.21%
773.69
594.19 593.17 500.92 659.83
Cost Of Revenue
102.37%
142.03
70.18 102.65 81.98 67.27
Gross Profit
20.54%
631.66
524.01 490.52 418.94 592.55
Operating Expenses
28.05%
647.86
505.93 595.68 495.84 543.94
Benefits Costs and Expenses
27.25%
809.05
635.78 787.12 609.58 670.99
Costs And Expenses
37.11%
789.89
576.11 698.33 577.82 611.21
Operating Income/Loss
189.61%
-16.20
18.08 -105.16 -76.91 48.61
Nonoperating Income/Loss
67.89%
-19.16
-59.67 -88.80 -31.76 -59.78
Income/Loss From Continuing Operations Before Tax
15.00%
-35.36
-41.60 -193.96 -108.66 -11.17
Income Tax Expense/Benefit, Deferred
1.00%
9.735
9.639 - - -
Income Tax Expense/Benefit
94.67%
30.92
15.88 -110.19 2.907 5.722
Income/Loss From Continuing Operations After Tax
15.31%
-66.28
-57.48 -83.76 -111.57 -16.89
Net Income/Loss
15.31%
-66.28
-57.48 -83.76 -111.57 -16.89
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.73%
130.63
129.68 0.492 128.59 126.73
Diluted Average Shares
0.73%
130.63
129.68 0.492 128.59 126.73
Basic Earnings Per Share
15.91%
-0.51
-0.44 -0.65 -0.87 -0.13
Diluted Earnings Per Share
15.91%
-0.51
-0.44 -0.65 -0.87 -0.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$578.42
price down icon 1.48%
$704.58
price down icon 0.44%
biotechnology ONC
$302.15
price up icon 0.67%
$136.57
price up icon 1.43%
$102.25
price down icon 0.74%
자본화:     |  볼륨(24시간):